Order Article Reprints

Goh NLL-A, Abdul Rahim NJ, Bhatt R, Ong SE, Lim KY, Gandini A, Zeng Z, Kumari S, Gabrielli B. Checkpoint Kinase 1 Inhibitor Combined with Low Dose Hydroxyurea Promotes ATM-Activated NF-κB-Dependent Pro-Inflammatory Chemokine Expression in Melanomas. Cancers. 2025; 17(11):1817. https://doi.org/10.3390/cancers17111817

Goh, Nicole Lisa Li-Ann, Nur Jannah Abdul Rahim, Rituparna Bhatt, Si En Ong, Khai Yee Lim, Anastasia Gandini, Zhen Zeng, Snehlata Kumari, and Brian Gabrielli. 2025. "Checkpoint Kinase 1 Inhibitor Combined with Low Dose Hydroxyurea Promotes ATM-Activated NF-κB-Dependent Pro-Inflammatory Chemokine Expression in Melanomas" Cancers 17, no. 11: 1817. https://doi.org/10.3390/cancers17111817

Goh, N. L. L.-A., Abdul Rahim, N. J., Bhatt, R., Ong, S. E., Lim, K. Y., Gandini, A., Zeng, Z., Kumari, S., & Gabrielli, B. (2025). Checkpoint Kinase 1 Inhibitor Combined with Low Dose Hydroxyurea Promotes ATM-Activated NF-κB-Dependent Pro-Inflammatory Chemokine Expression in Melanomas. Cancers, 17(11), 1817. https://doi.org/10.3390/cancers17111817